Dr. Andrew D. Tannenbaum, MD

Dr. Tannenbaum practices at Javon Bea Hospital in Rockford, Illinois.

Dr. Tannenbaum's NPI, 1972867315, was assigned on June 29, 2012. Dr. Tannenbaum graduated from Boston University School of Medicine in 2012. Dr. Tannenbaum holds Illinois license 036147111.

Dr. Tannenbaum's primary practice is Javon Bea Hospital, at 8201 E Riverside Blvd, Rockford, IL 61114 in Winnebago County. The practice phone is (815) 971-5000.

Dr. Tannenbaum's primary practice is Javon Bea Hospital in Rockford, Illinois. Dr. Tannenbaum is also affiliated with Javon Bea Hospital-Riverside. The medical group on file is Mercyhealth Physicians. Dmand AI also links Dr. Tannenbaum to 5 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tannenbaum practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Tannenbaum's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dmand AI has Dr. Tannenbaum's licenses on file in 2 states: Illinois and Massachusetts.

CMS data shows 318 Medicare services from Dr. Tannenbaum across 11 procedure codes in 2024, for 296 Medicare patients. Medicare paid $7,784 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 296 Medicare patients who saw Dr. Tannenbaum in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tannenbaum's median patient age at 71, with 57% women.

In 2024, Dr. Tannenbaum wrote 71 Medicare Part D claims for 24 patients. 62% of them were for generic drugs. CMS names the drug for 58 of them, across 2 drugs with 11 or more claims each, at $14,465 in total drug cost. In 2023, CMS named 39 claims across 2 drugs.

Dr. Tannenbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of varicose vein removal by Dr. Tannenbaum, more than 52% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 80 general payments to Dr. Tannenbaum from 18 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Penumbra, Inc. paid the most, $19,639.

Dr. Tannenbaum graduated from Boston University School of Medicine in 2012.